Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
These are treatable, and getting support earlier makes a difference
The pivotal STEP 1 trial demonstrated that participants receiving semaglutide 2.4 mg achieved an average weight loss of 14.9% of initial body weight over 68 weeks, compared to 2.4% with placebo
and MSD
The STEP 4 follow-up confirmed that weight regain occurs after discontinuation, establishing that obesity, like other chronic diseases, requires ongoing treatment for sustained benefit
US$ 22.95
US$ 23.28
US$ 22.63
US$ 22.30
US$ 25.04
US$ 28.44
US$ 25.36
US$ 27.35
